A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.
One new story for each specialty, every morning: short, sourced and readable between patients.
None of today's stories are in your chosen specialties. Change specialties or browse all of MedShorts 360.
In 8,323 patients with established cardiovascular disease and high Lp(a), monthly pelacarsen lowered Lp(a) sharply but MACE rates were the same as placebo (HR 1.02). Experts say Lp(a) testing remains useful for risk assessment.
The FDA now requires a warning on non-arteritic anterior ischaemic optic neuropathy for all GLP-1 receptor agonists. Absolute risk is low, but patients should report sudden painless vision loss in one eye and be referred promptly.
In 78,656 hospitalised adults, ibuprofen for acute pain was associated with 22% higher AKI rates than oxycodone, with excess risk concentrated in postoperative and critically ill patients. Low-risk patients showed no excess.
NeurologyThe FDA has approved oral asundexian 50 mg with antiplatelet therapy after non-cardioembolic ischaemic stroke or high-risk TIA. In OCEANIC-STROKE it cut ischaemic stroke by 26% without a significant rise in major bleeding.
UrologyAn updated meta-analysis of 29 studies (5,604 patients) found suction ureteral access sheaths roughly halved residual fragments, fever and sepsis versus traditional sheaths in RIRS, though most evidence is observational.
A secondary analysis of a 68-patient trial found that adding two ketamine-assisted sessions to mindfulness therapy in people on buprenorphine increased self-reported body awareness, which tracked with lower opioid craving later.
In a 1,695-patient pragmatic trial, metoprolol added to standard care in COPD patients without cardiovascular disease did not significantly reduce exacerbations, cardiovascular events or death over one year.
In a single-centre US cohort of 50,667 adult ICU patients, those with preexisting atrial fibrillation spent a larger share of ICU days delirious, an association that persisted after adjustment for baseline risk.
GastroenterologyA new AASLD Expert-Based Practice Opinion in Hepatology advises one-time HDV antibody testing for everyone who is HBsAg positive, RNA confirmation, elastography, six-monthly liver cancer surveillance and consideration of antiviral therapy.
A meta-analysis of 52 observational studies found that higher NO2, SO2, PM10 and PM2.5 levels were probably linked to higher atopic dermatitis prevalence and more outpatient visits in children, while evidence on new cases and severity was mixed.
JAMA Ophthalmology has named the Diabetes Endothelial Keratoplasty Study its first Clinical Trial of the Year. The trial found one-year DMEK graft success was about 96% to 97% whether or not the corneal donor had diabetes.
ENTA cross-sectional UK Biobank analysis found that worse speech-in-noise hearing was associated with modestly thinner macular and inner retinal layers. The differences were very small and the design cannot show cause or direction.
In a Canadian cohort of 1,296 patients who had walking difficulty before total knee arthroplasty, 60.6% had none a year later. Depression and low back pain lowered the odds of recovery, while self-efficacy and social support raised them.
Women with familial hypercholesterolaemia reported pre-eclampsia more often than matched controls (11% vs 7%), while other reproductive and pregnancy outcomes were similar, a Dutch-Norwegian study found.
Screen-capture data from 1,011 US youth aged 8 to 17 suggested a median of about 3,900 food marketing exposures a year, mostly on social media; over 90% of packaged products shown failed a nutrient standard.
A survey of 468 head and neck surgeons in 46 countries found routine antibiotics in clean thyroid surgery and prolonged courses after clean-contaminated cancer surgery were common, and having a guideline did not mean shorter courses.
In a stepped-wedge trial in six Australian hospitals involving 4,827 inpatients aged 65 or older, adding stewardship pharmacists raised deprescribing of sedative and anticholinergic drugs by 5.3 percentage points, but the gain faded once they were withdrawn.
Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.
Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.
MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.
The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.
Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.
Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.
Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.
Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.
When all three roles learn from the same source, the patient hears one consistent story about their treatment.
Learns the evidence, passes certification, shares an approved MedShorts link.
Reviews the update in minutes, prescribes with the latest guidance, shares patient material.
Dispenses correctly and counsels on dose, timing, side-effects and adherence.
Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.
Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.
Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.
Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.
Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.
Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.
A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.
One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.
Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.
Apply it in practice, share patient material, or continue to a full CME course.
Engagement flows into the brand dashboard and shapes the next content cycle.
Two-to-three-minute reads on a single clinical question.
Expert perspectives in three-to-five-minute clips.
Landmark and recent trials summarised with key numbers.
What changed, and what it means in clinic.
Test and reinforce, with instant explanations.
Leaflets and videos doctors and pharmacists can share.
Lung-sound and ECG trainers, calculators and checklists.
Interaction, storage and pharmacovigilance reminders.
MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.
The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.
Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.